Sustained Release Agent

Abstract This study aimed to address the challenges associated with the low oral bioavailability and the necessity for frequent dosing...

Abstract The “in situ gel” system has become one of the emerging drug delivery systems and plays a significant role...

Abstract Salbutamol sulphate (SS) is a widely prescribed β2 agonist for different respiratory disorders. However, its short plasma half-life and poor...

Abstract Background Rivastigmine (RT), exhibits low oral availability (40%) and high hepatic first-pass (36%). Circumventing the blood-brain barrier-related convolutions for...

Abstract Purpose: To prepare azithromycin (AZI) sustained-release suspension containing AZI-coated microcapsules (AZI-CM) impregnated with AZI-drug resin complex (AZI-DRC), in order...

Abstract Hydrogels have gained attention in drug delivery systems for their ability to encapsulate nanoparticles, providing sustained and targeted release....

Triton™ X-100 (tert-octyl phenyl ethoxylate) is a widely and extensively used non-ionic detergent in the biopharmaceutical industry, particularly in the...

Abstract In situ forming implants are appealing long-acting dosage forms for both preclinical and clinical applications due to their simple manufacturing...

The healthcare sector accounts for 4.4% of the world’s net global greenhouse emissions and 8% of emissions in France. Given this...

Abstract Treating diabetic retinopathy (DR) effectively is challenging, aiming for high efficacy with minimal discomfort. While intravitreal injection is the...